資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSIHS_EWB_GF

Interventional Radiology Market by Product (MRI System, Ultrasound Imaging System, CT Scanner, Angiography System), Procedures (Angiography, Angioplasty, Biopsy) & Application (Cardiology, Oncology, Urology & Nephrology) - Global Forecast to 2021

  • LinkedIn
  • facebook
  • Twitter
出 版 商:MarketsandMarkets
出版日期:2017/03/08
頁  數:160頁
文件格式:PDF
價  格:
USD 5,650 (Single-User License)
USD 6,650 (Multi-User License)
USD 8,150 (Global-User License)
線上訂購或諮詢
The global interventional radiology imaging market is expected to reach USD 23.50 billion by 2021 from USD 16.99 billion in 2016, at a CAGR of 6.7%. The market is broadly classified into product, procedures, and application.
On the basis of product, the market is segmented into angiography systems, fluoroscopy systems, CT scanners, ultrasound-imaging systems, MRI system, and other devices (C-arm, contrast media injectors, & imaging catheter guidewires). The MRI system segment is estimated to account for the largest share of the market in 2016. Factors such as technological advancements and product launches are driving the growth of this segment.
Based on procedure, the market is segmented into angiography, angioplasty, embolization, thrombolysis, vertebroplasty, nephrostomy, and other procedures (biliary drainage, fallopian tube recanalization, cholecystectomy, and carotid-cavernous fistula). The angiography segment is projected to witness the highest growth in this market due to increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive procedures.
By applications, the market is segmented into cardiology, oncology, urology & nephrology, gastroenterology, and other applications (orthopedics, neurology, and gynecology). The oncology segment is projected to witness the highest growth in this market due to increase in the incidence of cancer and rising demand for minimally invasive procedures.

Geographically, the market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by the increase in the prevalence and incidence of chronic diseases and the aging population.
The key players in the market include GE Healthcare (General Electric Company) (U.K.), Siemens Healthcare GmBH (Siemens AG) (Germany), Koninklijke Philips N.V. (The Netherlands), Toshiba Medical Systems Corporation (Toshiba Corporation) (Japan), Hitachi Medical Corporation (Hitachi Ltd.) (Japan), Carestream Health, Inc. (U.S.), Esaote S.p.A (Italy), Hologic, Inc. (U.S.), Fujifilm Corporation (Japan), Samsung Medison (South Korea), and Shimadzu Corporation (Japan).
Research Coverage:
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of the future trends will help market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies to strengthen their market shares.

The report provides insights on the following pointers:

‧ Market Penetration: Comprehensive information on the product portfolios of the top players in the interventional radiology imaging market. The report analyses the interventional radiology imaging market: by product, by procedure, and by application.
‧ Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the interventional radiology imaging market
‧ Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the interventional radiology imaging market
‧ Market Development: Comprehensive information about emerging markets. This report analyzes the market for various interventional radiology imaging products across geographies
‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the interventional radiology imaging market
TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKET COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 SECONDARY DATA 18
2.1.1 KEY DATA FROM SECONDARY SOURCES 18
2.2 PRIMARY DATA 19
2.2.1 KEY DATA FROM PRIMARY SOURCES 20
2.3 MARKET SIZE ESTIMATION 21
2.3.1 BOTTOM-UP APPROACH 21
2.3.2 TOP-DOWN APPROACH 22
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 23
2.5 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
3.1 INTRODUCTION 25
3.2 CONCLUSION 29
4 PREMIUM INSIGHTS 30
4.1 INTERVENTIONAL RADIOLOGY: MARKET OVERVIEW 30
4.2 INTERVENTIONAL RADIOLOGY MARKET, BY PRODUCT AND REGION (2016) 31
4.3 LIFE CYCLE ANALYSIS, BY REGION 32
5 INDUSTRY INSIGHTS 33
5.1 INTRODUCTION 33
5.2 PORTER’S FIVE FORCES ANALYSIS 34
5.2.1 THREAT OF NEW ENTRANTS 35
5.2.2 THREAT OF SUBSTITUTES 35
5.2.3 BARGAINING POWER OF BUYERS 35
5.2.4 BARGAINING POWER OF SUPPLIERS 35
5.2.5 INTENSITY OF RIVALRY 36
?
5.3 SUPPLY CHAIN ANALYSIS 36
5.4 KEY INFLUENCERS 37
6 MARKET OVERVIEW 38
6.1 INTRODUCTION 39
6.2 MARKET DYNAMICS 39
6.2.1 DRIVERS 40
6.2.1.1 Rising incidence and prevalence of chronic diseases 40
6.2.1.2 Increasing demand for minimally invasive procedures 41
6.2.1.3 Technological advancements in Interventional Radiology devices 41
6.2.2 RESTRAINTS 42
6.2.2.1 Risk of high radiation exposure to limit the use of CT scanners 42
6.2.2.2 Shortage of Helium - a major concern for MRI manufacturers and healthcare facilities 42
6.2.3 OPPORTUNITIES 43
6.2.3.1 Emerging markets 43
6.2.4 CHALLENGES 44
6.2.4.1 Entry barriers for new players 44
6.2.4.2 Hospital budget cuts 44
6.2.4.3 Increasing adoption of refurbished Interventional Radiology systems 45
7 INTERVENTIONAL RADIOLOGY MARKET, BY PRODUCT 46
7.1 INTRODUCTION 47
7.2 MRI SYSTEMS 49
7.3 ULTRASOUND IMAGING SYSTEMS 50
7.4 CT SCANNERS 51
7.5 ANGIOGRAPHY SYSTEMS 52
7.6 FLUOROSCOPY SYSTEMS 53
7.7 BIOPSY DEVICES 54
7.8 OTHER DEVICES 55
8 INTERVENTIONAL RADIOLOGY MARKET, BY PROCEDURE 56
8.1 INTRODUCTION 57
8.2 ANGIOGRAPHY 58
8.3 ANGIOPLASTY 59
8.4 BIOPSY AND DRAINAGE 60
8.5 EMBOLIZATION 61
8.6 THROMBOLYSIS 62
8.7 VERTEBROPLASTY 63
8.8 NEPHROSTOMY 64
8.9 OTHER PROCEDURES 65
?
9 INTERVENTIONAL RADIOLOGY MARKET, BY APPLICATION 66
9.1 INTRODUCTION 67
9.2 CARDIOLOGY 68
9.3 UROLOGY & NEPHROLOGY 69
9.4 ONCOLOGY 70
9.5 GASTROENTEROLOGY 72
9.6 OTHER APPLICATIONS 73
10 INTERVENTIONAL RADIOLOGY MARKET, BY REGION 74
10.1 INTRODUCTION 75
10.2 NORTH AMERICA 76
10.2.1 U.S. 80
10.2.2 CANADA 82
10.3 EUROPE 85
10.3.1 GERMANY 88
10.3.2 FRANCE 91
10.3.3 U.K. 93
10.3.4 ITALY 95
10.3.5 REST OF EUROPE 97
10.4 ASIA 99
10.5 REST OF THE WORLD (ROW) 104
11 COMPETITIVE LANDSCAPE 108
11.1 OVERVIEW 108
11.2 MARKET SHARE ANALYSIS 109
11.3 COMPETITIVE SITUATION AND TRENDS 110
11.3.1 PRODUCT LAUNCHES 111
11.3.2 AGREEMENTS, COLLABORATIONS & PARTNERSHIPS 112
11.3.3 APPROVALS 113
11.3.4 EXPANSIONS 114
11.3.5 ACQUISITIONS 114
11.3.6 OTHER DEVELOPMENTS 115
12 COMPANY PROFILE 116
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 INTRODUCTION 116
12.2 GE HEALTHCARE (A FULLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 117
12.3 SIEMENS AG 121
12.4 KONINKLIJKE PHILIPS N.V. 126
12.5 TOSHIBA MEDICAL SYSTEMS CORPORATION (TOSHIBA CORPORATION) 130
12.6 HITACHI MEDICAL CORPORATION (HITACHI LTD.) 134
12.7 CARESTREAM HEALTH 137
12.8 ESAOTE S.P.A. 139
12.9 HOLOGIC INC. 141
12.10 SHIMADZU CORPORATION 143
12.11 SAMSUNG MEDISON 145
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
13 APPENDIX 147
13.1 INDUSTRY INSIGHTS 147
13.2 DISCUSSION GUIDE 148
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 152
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 154
13.5 AVAILABLE CUSTOMIZATIONS 155
13.6 RELATED REPORTS 156
13.7 AUTHOR DETAILS 157
回上頁